Trial Profile
Insulin combined with the DPP-4 inhibitor sitagliptin for diabetes: evaluation study
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 25 May 2018
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Insulin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- Acronyms I-UNITE
- 16 May 2018 Status changed from recruiting to active, no longer recruiting.
- 06 Aug 2013 New trial record